Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas
Authors
Keywords
Children, DNA methylation profiles, Gliomatosis cerebri, Molecular classification
Journal
ACTA NEUROPATHOLOGICA
Volume 131, Issue 2, Pages 299-307
Publisher
Springer Nature
Online
2016-01-07
DOI
10.1007/s00401-015-1532-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
- (2015) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Gliomatosis cerebri: no evidence for a separate brain tumor entity
- (2015) Ulrich Herrlinger et al. ACTA NEUROPATHOLOGICA
- Pediatric Gliomatosis Cerebri
- (2015) Emilie George et al. JOURNAL OF CHILD NEUROLOGY
- Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
- (2014) Martin J. Aryee et al. BIOINFORMATICS
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- Primary gliomatosis cerebri involving gray matter in pediatrics: a distinct entity? A multicenter study of 14 cases
- (2013) Céline Chappé et al. CHILDS NERVOUS SYSTEM
- Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma
- (2013) Sadhana Jackson et al. JOURNAL OF NEURO-ONCOLOGY
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma
- (2013) A. Broniscer et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
- (2012) Pierre Bady et al. ACTA NEUROPATHOLOGICA
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
- Mutated IDH1 Is a Favorable Prognostic Factor for Type 2 Gliomatosis Cerebri
- (2011) Mi Jung Kwon et al. BRAIN PATHOLOGY
- IDH1mutation, a genetic alteration associated with adult gliomatosis cerebri
- (2011) Deepti Narasimhaiah et al. NEUROPATHOLOGY
- Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes
- (2010) Marcel Seiz et al. ACTA NEUROPATHOLOGICA
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Correlative analysis of gene expression profile and prognosis in patients with gliomatosis cerebri
- (2009) Oscar Fernando D'Urso et al. CANCER
- Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma
- (2008) Xiaolong Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Array-based comparative genomic hybridization and immunohistochemical studies in gliomatosis cerebri
- (2008) Hye Sook Min et al. JOURNAL OF NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started